These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24011247)

  • 21. Treatment of Helicobacter pylori infection 2010.
    O'Connor A; Gisbert JP; McNamara D; O'Morain C
    Helicobacter; 2010 Sep; 15 Suppl 1():46-52. PubMed ID: 21054653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea.
    Lee BH; Kim N; Hwang TJ; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Helicobacter; 2010 Feb; 15(1):38-45. PubMed ID: 20302588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Helicobacter pylori infection 2012.
    Tepes B; O'Connor A; Gisbert JP; O'Morain C
    Helicobacter; 2012 Sep; 17 Suppl 1():36-42. PubMed ID: 22958154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
    McNicholl AG; Marin AC; Molina-Infante J; Castro M; Barrio J; Ducons J; Calvet X; de la Coba C; Montoro M; Bory F; Perez-Aisa A; Forné M; Gisbert JP;
    Gut; 2014 Feb; 63(2):244-9. PubMed ID: 23665990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eradication of Helicobacter pylori infection.
    Wu TS; Hu HM; Kuo FC; Kuo CH
    Kaohsiung J Med Sci; 2014 Apr; 30(4):167-72. PubMed ID: 24656156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment for H. pylori infection: new challenges with antimicrobial resistance.
    Vakil N; Vaira D
    J Clin Gastroenterol; 2013; 47(5):383-8. PubMed ID: 23388847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer].
    Gisbert JP
    Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():15-26. PubMed ID: 22330153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Helicobacter pylori.
    Bytzer P; O'Morain C
    Helicobacter; 2005; 10 Suppl 1():40-6. PubMed ID: 16178970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
    Fischbach L; Evans EL
    Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
    Gisbert JP; Pajares JM
    Helicobacter; 2005 Oct; 10(5):363-72. PubMed ID: 16181345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection.
    Venerito M; Krieger T; Ecker T; Leandro G; Malfertheiner P
    Digestion; 2013; 88(1):33-45. PubMed ID: 23880479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
    Fakheri H; Taghvaei T; Hosseini V; Bari Z
    Helicobacter; 2012 Feb; 17(1):43-8. PubMed ID: 22221615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Helicobacter pylori.
    Wolle K; Malfertheiner P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):315-24. PubMed ID: 17382279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).
    Marin AC; McNicholl AG; Gisbert JP
    Expert Opin Pharmacother; 2013 May; 14(7):843-61. PubMed ID: 23537368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonbismuth quadruple "concomitant" therapy versus standard triple therapy, both of the duration of 10 days, for first-line H. pylori eradication: a randomized trial.
    Georgopoulos S; Papastergiou V; Xirouchakis E; Laoudi F; Lisgos P; Spiliadi C; Papantoniou N; Karatapanis S
    J Clin Gastroenterol; 2013 Mar; 47(3):228-32. PubMed ID: 22858517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Second-line therapy for Helicobacter pylori].
    Asaoka D; Nagahara A; Hojo M; Sasaki H; Watanabe S
    Nihon Rinsho; 2013 Aug; 71(8):1399-403. PubMed ID: 23967670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.